Seiya Kitamura

Seiya Kitamura is an Assistant Professor in the Department of Biochemistry at Albert Einstein College of Medicine. His research focuses on advancing chemical biology and medicinal chemistry to address global health challenges, particularly in antiviral therapies and host-microbe interactions. His laboratory develops innovative methodologies such as SuFEx-enabled high-throughput drug discovery platforms and explores new modalities for small molecules, including protein degradation and activation functions.

Research interests include:

• Development of cutting-edge methodologies in medicinal chemistry
• Chemical biology of host-microbe interactions, including microbiome and infectious diseases
• Expansion of small molecule functional capabilities beyond traditional inhibition

Key research trends in his articles emphasize:

• Antiviral drug discovery targeting influenza and other pathogens
• PROTAC-based protein degradation technologies
• Molecular glue discovery for CRBN protein modulation
• Application of SuFEx chemistry in high-throughput screening

His work bridges basic science and translational medicine, aiming to address urgent public health needs such as pandemic preparedness and antibiotic resistance. No scientific awards are explicitly listed, though his prolific publication record reflects significant contributions to the field.

Advising and grants: While student names aren't listed, Kitamura collaborates extensively with multidisciplinary teams. His lab focuses on translational research with potential clinical applications. No specific grant information is provided in the text.

Labs/teams: Leads a research group actively engaged in chemical biology and drug discovery projects, collaborating with institutions like Scripps Research and The Scripps Research Institute (TSRI).